Cell Culture Media are used to provide nutrients for cells growth in research, diagnostic and manufacturing applications. Typical cell culture media contain a mixture of defined nutrients dissolved in a buffered physiological saline solution. In cell culture, media are used to facilitate the growth of cells. Media are water-based liquids that can be provided in liquid or in dry powder format. Dry powder media has to be hydrated with water or with process liquids. Process liquids are water-based buffers and saline solutions which facilitate the cell culture process and ensure that the cell culture environment remains at a constant pH.
This report contains market size and forecasts of Cell Culture Media for Vaccine in global, including the following market information:
Global Cell Culture Media for Vaccine Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Cell Culture Media for Vaccine Market Sales, 2017-2022, 2023-2028, (K L)
Global top five Cell Culture Media for Vaccine companies in 2021 (%)
The global Cell Culture Media for Vaccine market was valued at 941.5 million in 2021 and is projected to reach US$ 1539.1 million by 2028, at a CAGR of 7.3% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
With Serum Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Cell Culture Media for Vaccine include Thermo Fisher, Merck, Corning, Cytiva, Lonza, Fujifilm, Sartorius Stedim Biotech, HiMedia Laboratories and ProCellTM, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Cell Culture Media for Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cell Culture Media for Vaccine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K L)
Global Cell Culture Media for Vaccine Market Segment Percentages, by Type, 2021 (%)
With Serum
Serum-free
Global Cell Culture Media for Vaccine Market, by End User, 2017-2022, 2023-2028 ($ Millions) & (K L)
Global Cell Culture Media for Vaccine Market Segment Percentages, by End User, 2021 (%)
Human Vaccine
Animal Vaccine
Global Cell Culture Media for Vaccine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K L)
Global Cell Culture Media for Vaccine Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cell Culture Media for Vaccine revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Cell Culture Media for Vaccine revenues share in global market, 2021 (%)
Key companies Cell Culture Media for Vaccine sales in global market, 2017-2022 (Estimated), (K L)
Key companies Cell Culture Media for Vaccine sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Thermo Fisher
Merck
Corning
Cytiva
Lonza
Fujifilm
Sartorius Stedim Biotech
HiMedia Laboratories
ProCellTM
Jianshun Biosicences
Shanghai OPM Biosciences
Zhenge Biotech

LEAVE A REPLY

Please enter your comment!
Please enter your name here